ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1228

Central Pain Mechanisms and Physical Function in Early Rheumatoid Arthritis

Burcu Aydemir1, Lutfiyya Muhammad2, Jing Song3, Dorothy Dunlop4, Kathleen Aren5, Mary Carns5, Wendy Marder6, Vivian Bykerk7, Kevin Deane8, Clifton Bingham9 and Yvonne Lee1, 1Northwestern University, Chicago, IL, 2Northwestern Feinberg School of Medicine, Chicago, IL, 3Northwestern University, Worthington, MN, 4Northwestern University, New Haven, CT, 5Northwestern University Division of Rheumatology, Chicago, IL, 6University of Michigan, Ann Arbor, MI, 7Hospital For Special Surgery, New York, NY, 8University of Colorado Denver Anschutz Medical Campus, Aurora, CO, 9Johns Hopkins University, Baltimore, MD

Meeting: ACR Convergence 2024

Keywords: pain, physical function, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 17, 2024

Title: Pain in Rheumatic Disease Including Fibromyalgia Poster

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Despite effective control of inflammation, patients with rheumatoid arthritis (RA) may experience lingering pain and losses in physical function. Pain can occur because central nervous system (CNS) pain processing becomes dysregulated. Altered CNS pain regulation can lead to heightened pain perception and widespread pain sensitivity that may limit physical function. In this study, we examined associations between CNS pain regulation, pain intensity, and number of painful body sites with physical function during the early stages of RA. We hypothesized that abnormalities in CNS pain regulation, higher pain intensity, and a greater number of painful body sites would be associated with lower physical function in patients with early RA.

Methods: Cross-sectional baseline data were analyzed from adults with early RA enrolled in the on-going Central Pain in RA 2 (CPIRA-2) study. Eligible participants met the ACR/EULAR 1987 or 2010 criteria for RA, had persistent joint symptoms for ≤ 24 months, and active disease. Physical function was assessed by the PROMIS physical function questionnaire, which measures functional capability of different body regions and activities of daily living. Quantitative sensory tests (QST), including pressure pain threshold (PPT), temporal summation (TS), and conditioned pain modulation (CPM), were performed to assess mechanisms of CNS pain regulation. PPT measures overall pain sensitization, while TS and CPM assess ascending (pain facilitation) and descending (pain inhibition) analgesic pathways, respectively. Pain intensity was assessed using a 0-10 numeric rating scale, and the number of painful body sites was assessed using the CHOIR body map. Spearman’s correlations were computed to examine bivariate associations between each pain measure and physical function. Separate linear regression models estimated unadjusted and adjusted associations between each QST measure, pain intensity, number of painful body sites, and physical function, adjusting for age, sex, body mass index (BMI), and swollen joint count.

Results: Our sample included 68 patients (81% female, 85% white) with mean (SD) age of 52.9 (16.6) years, BMI of 28.6 (7.3) kg/m2, and RA symptom duration of 0.8 (0.4) months (Table 1).  Approximately 65% had mild to severe functional limitations (t-score ≤ 45). Higher PPTs (trapezius and wrist), lower TS at the wrist, greater pain intensity, and more painful body sites were each associated with lower physical function (Table 2). In adjusted models, greater pain intensity (β = -1.9 [95% CI -2.5 to -1.3]) and more painful body sites (β = -0.20 [95% CI -0.36 to -0.04]) remained significantly associated with poor physical function (Table 3).

Conclusion: Among patients with early RA, a phenotypic pain profile comprised of high pain sensitization, high pain intensity, and many painful body sites was associated with poor physical function. Incorporating pain management strategies in patients with early RA may help them maintain physical function. Longitudinal work is needed to explore causal pain pathways and identify interventions that may be in addition to DMARD therapy to improve long-term physical function and quality of life related to pain pathways.

Supporting image 1

Supporting image 2

Supporting image 3


Disclosures: B. Aydemir: None; L. Muhammad: None; J. Song: None; D. Dunlop: None; K. Aren: None; M. Carns: None; W. Marder: None; V. Bykerk: BMS, 5, Pfizer, 1; K. Deane: Boehringer-Ingelheim, 5, Bristol-Myers Squibb(BMS), 6, Gilead, 5, Inova, 6, 12, Material Support, ThermoFisher, 5, 6; C. Bingham: AbbVie/Abbott, 2, Bristol-Myers Squibb(BMS), 5, Eli Lilly, 2, sanofi, 2; Y. Lee: Cigna-Express Scripts, 8, CVS Health, 8, GE Healthcare, 8.

To cite this abstract in AMA style:

Aydemir B, Muhammad L, Song J, Dunlop D, Aren K, Carns M, Marder W, Bykerk V, Deane K, Bingham C, Lee Y. Central Pain Mechanisms and Physical Function in Early Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/central-pain-mechanisms-and-physical-function-in-early-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/central-pain-mechanisms-and-physical-function-in-early-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology